Proton Pump Inhibitor Use is Associated With Risk of Pancreatic Cancer: A Nested Case–Control Study

PURPOSE: To investigate the use of proton pump inhibitors (PPIs) and the risk of pancreatic cancer. METHODS: A nested case–control analysis was conducted. Patients with pancreas cancer were matched with controls by propensity score. Univariate and multivariate logistic regression models were used to...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Yen-Chun, Lin, Cheng-Li, Hsu, Wan-Yun, Lu, I-Ta, Yeh, Hong-Zen, Chang, Chi-Sen, Kao, Chia-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168731/
https://www.ncbi.nlm.nih.gov/pubmed/30288155
http://dx.doi.org/10.1177/1559325818803283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168731/
https://www.ncbi.nlm.nih.gov/pubmed/30288155
http://dx.doi.org/10.1177/1559325818803283

Ejemplares similares